期刊文献+

miRNA-101在甲状腺髓样癌中抑癌机制的研究 被引量:8

Insights into tumor suppression mechanism of miRNA-101 in medullary thyroid carcinoma
下载PDF
导出
摘要 目的:研究microRNA-101在甲状腺髓样细胞中的抑癌机制。方法:首先用荧光定量PCR技术检测甲状腺髓样癌组织中microRNA-101的表达。接着采用microRNA-101模拟物干预法,并用流式细胞仪技术,Transwell实验等方法,对实验组和对照组细胞的增殖、迁移和凋亡进行比较。此外,还通过Western blot、报告基因检测法、流式细胞仪技术和Transwell实验确定miRNA-101靶基因以及相应的抑癌机制。结果:miRNA-101在甲状腺髓样癌组织中的表达相比癌旁组织下调(P<0.01)。与阴性对照组相比,miRNA-101模拟物转染组的甲状腺髓样癌细胞的增殖和迁移受到显著抑制,而凋亡率显著提高。Western blot和荧光素酶报告实验证实SOX9基因是miRNA-101下游的靶基因并被其下调。SOX9基因敲除可抑制甲状腺髓样癌细胞增殖,迁移和促进癌细胞凋亡。结论:microRNA-101通过靶向下调SOX9基因的表达抑制甲状腺髓样癌细胞的增殖和迁移,加速甲状腺髓样癌细胞的凋亡。 AIM: To explore the tumor suppression mechanism of microRNA-101 in human medullary thyroid carcinoma cells( TT cells). METHODS: The expression of microRNA-101 in tissue samples from patients with medullary thyroid carcinoma was analyzed by quantitative RT-PCR. Then TT cells were divided into two groups and transfected with miRNA-101 mimics/negative control. Flow cytometry and Transwell assay were used to detect TT cell cycle distribution,apoptotic rate as well as cell migration. Moreover,Western blot,flow cytometry,luciferase and Transwell assays were used to predict target gene of miRNA-101 as well as its underlying mechanism. RESULTS: MiRNA-101 was significantly down-regulated in medullary thyroid carcinoma tissues. MiRNA-101 mimics' transfection significantly inhibited TT cell proliferation and migration,induced cell apoptosis comparing with negative control. Western blot and luciferase assay revealed that SOX9 gene expression was down-regulated by miRNA-101. Silencing of SOX9 by siRNA showed similar effects with miRNA-101 over-expression. CONCLUSION: MicroRNA-101 inhibits proliferation,migration and induces apoptosis of human medullary thyroid carcinoma cells by targeting SOX9 gene.
作者 徐明 崔鹏 叶敏 倪熊 王廷峰 闵志钧 XU Ming;CUI Peng;YE Min;NI Xiong;WANG Tingfeng;MIN Zhijun(Department of General Surgery, Shanghai Pudong Hospital, Pudong Hospital Affiliated to Fudan Shanghai 201300, China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2018年第5期524-530,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 上海市卫生和计划生育委员会科研项目(201440467)
关键词 甲状腺髓样癌细胞 microRNA-101 SOX9 medullary thyroid carcinoma cells microRNA-101 SOX9
  • 相关文献

参考文献4

二级参考文献23

  • 1黄爱兵,邱勇,钱邦平.SOX9家族在软骨细胞生命周期的调控作用[J].中国骨与关节外科,2008,1(Z1):329-333. 被引量:4
  • 2李树玲:刘科 张仑.甲状腺癌[A].见:季树玲 主编.头颈肿瘤学[C].天津:天津科学技术出版社,1993.712-761.
  • 3Frankenthaler RA, Sellin RV, Cangir A, et al. lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg,1990,160: 341-343.
  • 4Mirallie E, Visset J, Sagan C, et al . Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg, 1999,23 : 970-973.
  • 5van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypezcalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.Ann Surg, 1990,212:395-400.
  • 6Marzano LA, Porcelli A, Biondi B,et al. Surgical management and followup of medullary thyroid carcinoma.J Surg Oncol, 1995,59:162-168.
  • 7Tisell LE, Hansson G, Jansson S, et al. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Smgery, 1986,99:60-66.
  • 8Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: a retrospective study of 109 consecutive patients. Cancer, 1996,78:2173-2183.
  • 9Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol, 1998,5:81-86.
  • 10Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: result in 899 patients. The GETC Study Group. Groupe d' etude des tumeurs a calcitonine. Clin Endocrino; 1998.48:265-273.

共引文献44

同被引文献55

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部